BEDFORD, MA--(Marketwire - September 1, 2010) -  Insulet Corporation (NASDAQ: PODD), the leader in tubing-free insulin pump technology with its OmniPod® Insulin Management System, today announced the Company will participate in several upcoming investor conferences. These conferences include:

  • The Rodman and Renshaw 12th Annual Healthcare Conference taking place September 13 - 15, 2010 at the New York Palace Hotel in New York City. Management is scheduled to present on Tuesday, September 14, 2010 at 11:15 a.m. ET.

  • The Stifel Nicolaus Healthcare Conference taking place September 15 - 17, 2010 at the Four Seasons in Boston. Management is scheduled to present on Thursday, September 16, 2010 at 11:30 a.m. ET.

  • The Fourth Annual JMP Securities Healthcare Focus Conference taking place September 27 - 29, 2010 at the New York Palace Hotel in New York City. Management is scheduled to present on Monday, September 27, 2010 at 4:00 p.m. ET.

During the presentations, material information concerning the Company, its operations, strategies and prospects may be discussed. To listen to the audio webcast of the presentation during the events, please visit: A replay of the webcasts will be available for 30 days.

About Insulet Corporation

Insulet Corporation is an innovative medical device company dedicated to improving the lives of people with diabetes. The Company's OmniPod Insulin Management System is a revolutionary, discreet and easy-to-use insulin infusion system that features two easy-to-use parts with no tubing and fully-automated cannula insertion. Through the OmniPod System, Insulet seeks to expand the use of continuous subcutaneous insulin infusion (CSII) therapy among people with insulin-dependent diabetes. Founded in 2000, Insulet is based in Bedford, MA.

Contact Information:

Stephanie Marks for Insulet Corporation

877-PODD-IR1 (877-763-3471)